(XD9U) MSCI USA 1C - Overview
Etf: Equities, Large-Cap, Mid-Cap, Usa
| Risk 5d forecast | |
|---|---|
| Volatility | 14.6% |
| Relative Tail Risk | -3.59% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.14 |
| Alpha | -6.31 |
| Character TTM | |
|---|---|
| Beta | 0.220 |
| Beta Downside | 0.467 |
| Drawdowns 3y | |
|---|---|
| Max DD | 23.68% |
| CAGR/Max DD | 0.73 |
Description: XD9U MSCI USA 1C January 08, 2026
The Xtrackers MSCI USA UCITS ETF 1C (XD9U) seeks to mirror the pre-fee, pre-expense performance of the MSCI Total Return Net USA Index, which tracks large- and mid-cap U.S. equities on a total-return basis (dividends are reinvested after tax). The fund aims for full physical replication, buying all-or, in rare cases, a representative subset-of the index constituents in the exact weightings.
Key quantitative details (as of early 2026) include an expense ratio of 0.09 % and a tracking error of roughly 3 bps over the past year, reflecting tight replication efficiency. The ETF holds approximately €5 bn in assets under management, with a weighted average dividend yield near 1.8 % and a 12-month total return of about 12 % (USD). Its sector exposure is dominated by Information Technology (≈25 %), Health Care (≈13 %) and Consumer Discretionary (≈12 %), making it sensitive to U.S. consumer spending trends and Federal Reserve interest-rate policy.
For a deeper dive into valuation metrics, risk factors, and scenario analysis, you might explore ValueRay.
What is the price of XD9U shares?
Over the past week, the price has changed by -0.10%, over one month by -1.52%, over three months by +0.10% and over the past year by +0.16%.
Is XD9U a buy, sell or hold?
What are the forecasts/targets for the XD9U price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 193.1 | 12.6% |
XD9U Fundamental Data Overview February 03, 2026
Revenue TTM = 0.0 EUR
EBIT TTM = 0.0 EUR
EBITDA TTM = 0.0 EUR
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 4.99b EUR (4.99b + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
EV/FCF = unknown (FCF TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 4.99b)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 4.99b / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 25.0% (EU avg default 25%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 25.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 6.72% (E(4.99b)/V(4.99b) * Re(6.72%) + (debt-free company))
Discount Rate = 6.72% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Fair Price DCF = unknown (Cash Flow 0.0)